By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development
•
February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy